Brief: Neovacs Granted A New Patent From Russian Federation Patent Office (Rospatent)
Jan 16 (Reuters) - NEOVACS SA ALNEV.PA :
* GRANTED A NEW PATENT FROM RUSSIAN FEDERATION PATENT OFFICE (ROSPATENT)
* PATENT STRENGTHENS NEOVACS' INTERFERON ALPHA (IFNALPHA)-RELATED INTELLECTUAL PROPERTY
PORTFOLIO
* PATENT UNTIL AT LEAST 2032
Source text for Eikon: ID:nGNE6lZ1BS
Further company coverage: ALNEV.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants